Revenue - Rollforward of Accounts Receivable (Details) $ in Thousands |
6 Months Ended |
|---|---|
|
Jun. 30, 2026
USD ($)
| |
| Accounts Receivable, After allowance for Credit Loss, Current [Roll Forward] | |
| Beginning balance at December 31, 2025 | $ 573 |
| Increase in accounts receivable for drug product sales | 6,353 |
| Decrease in accounts receivable for cash collections | (4,879) |
| Balance as of June 30, 2026 | $ 2,047 |